- Home
- CCCC vs LSBK Comparison
CCCC vs LSBK Comparison
Compare CCCC & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- LSBK
- Stock Information
- Founded
- CCCC 2015
- LSBK 1891
- Country
- CCCC United States
- LSBK United States
- Employees
- CCCC N/A
- LSBK N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- LSBK Savings Institutions
- Sector
- CCCC Health Care
- LSBK Finance
- Exchange
- CCCC Nasdaq
- LSBK Nasdaq
- Market Cap
- CCCC 104.4M
- LSBK 90.0M
- IPO Year
- CCCC 2020
- LSBK 2006
- Fundamental
- Price
- CCCC $2.46
- LSBK $12.66
- Analyst Decision
- CCCC Buy
- LSBK
- Analyst Count
- CCCC 2
- LSBK 0
- Target Price
- CCCC $8.00
- LSBK N/A
- AVG Volume (30 Days)
- CCCC 1.5M
- LSBK 115.7K
- Earning Date
- CCCC 08-07-2025
- LSBK 07-23-2025
- Dividend Yield
- CCCC N/A
- LSBK 2.84%
- EPS Growth
- CCCC N/A
- LSBK 40.80
- EPS
- CCCC N/A
- LSBK 1.05
- Revenue
- CCCC $34,240,000.00
- LSBK $26,488,000.00
- Revenue This Year
- CCCC N/A
- LSBK N/A
- Revenue Next Year
- CCCC N/A
- LSBK N/A
- P/E Ratio
- CCCC N/A
- LSBK $12.09
- Revenue Growth
- CCCC 16.55
- LSBK 1.75
- 52 Week Low
- CCCC $1.09
- LSBK $11.50
- 52 Week High
- CCCC $7.22
- LSBK $12.92
- Technical
- Relative Strength Index (RSI)
- CCCC 59.48
- LSBK 65.45
- Support Level
- CCCC $1.95
- LSBK $12.64
- Resistance Level
- CCCC $2.94
- LSBK $12.92
- Average True Range (ATR)
- CCCC 0.26
- LSBK 0.16
- MACD
- CCCC 0.00
- LSBK 0.03
- Stochastic Oscillator
- CCCC 51.52
- LSBK 71.74
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.